with synovial sarcoma treated at 2 US centers and 1 Italian center between 1966 and 1999, the analysis included 45 patients with localized disease that could not be resected (group 3). Among these patients, the event-free survival at 5 years was 76% ± 8% if treated with radiation therapy and only 36% ± 13% if radiation was not given (P = .03). 1, 4 The role of chemotherapy in the control of this illness is more controversial. In the same retrospective review, 4 42 patients with localized disease received chemotherapy, and there was sufficient information about 30 of these patients to demonstrate a 60% complete or partial response to chemotherapy. However, there was insufficient information to show that chemotherapy significantly affected long-term prognosis among these patients.
In a phase II trial of vincristine, doxorubicin, and ifosfamide in children with nonrhabdomyosarcoma sarcomas, there were 16 patients with unresectable or metastatic synovial sarcoma. Nine of these 16 patients (56%) had a partial or complete response to chemotherapy. The progression-free survival for the synovial sarcoma patients was 56.3% at 3 years. Again, there was insufficient data to conclude that the responding patients had an improved long-term prognosis. 5 The inability to definitely show that prolonged survival is associated with chemotherapy among these patients is primarily due to the small numbers of patients and the lack of randomized trials. Given the documented response rates to chemotherapy among synovial sarcoma patients, regimens that include ifosfamide and/or cyclophosphamide and doxorubicin are generally recommended for young patients. A definitive answer to the role of chemotherapy in children with synovial sarcoma must await further prospective studies. 
Linda Granowetter, MD

Nutrition Intervention
The objectives of the nutrition prescription for this patient include (1) support growth and development during cancer therapy, (2) provide immune support, and (3) provide support for the management of side effects of chemotherapy and radiation therapy.
In developing a nutritional plan for pediatric patients with cancer, it is crucial to formulate recommendations that are feasible within the family structure and its financial resources. A comprehensive interview with the family to review their current dietary practices and to provide solutions that work within the current family practice is critical to the success of the nutrition recommendations. Dietary improvements are more likely to be accepted by the family and the child with cancer when a strong family network is available and sibling support is provided. Consistent dietary messages from the mother, father, guardians, and caregivers will facilitate dietary change within the family. Upon the child's completion of cancer therapy, the adoption of more challenging guidelines may be more feasible.
To aid in the successful implementation of nutrition recommendations, the practitioner should consider recommending interventions that retain a wide spectrum of clinical effect so as to minimize the number of dietary interventions and supplements required by the child with cancer. This will also help ensure compliance with the nutrition recommendations.
Growth Support
One of the challenges in counseling children with cancer as compared with adults is the need to support growth and development while the child is receiving the recommended anticancer therapy. The practitioner needs to ensure that the patient is meeting all of his or her caloric needs, but this can be challenging to the practitioner because of the difficulties in ensuring that the child is eating a variety of foods. The chemotherapy and radiation therapy administered to this child are associated with taste alterations, thereby creating added difficulties in ensuring that he is ingesting a variety of foods. For this patient, this necessitated the recommendation for a multivitamin supplement as well as the placement of a percutaneous gastrostomy tube (PEG) to aid the child in meeting his total caloric needs.
Instead of administering nutrition formulas, this family was counseled on administering pureed foods through the PEG. This allowed the patient to continue to receive a varied diet, as well as critical phytonutrients, vitamins, minerals, and essential fatty acids found in foods. A nutrition prescription was developed that adhered to the fundamentals of an antiinflammatory diet. This dietary regimen emphasized fruit and vegetables, whole grains, fish, and beans. Food safety practices were reviewed as a precaution because of his compromised immune system. This included thorough flushing and cleaning of the PEG to reduce the risk of infection and prevent clogging of the PEG tube.
Immune Support
Immune support in the form of nutrition therapy was developed to aid in the tolerance of chemotherapy and radiation, minimization of therapy-related toxicity, and support of the cytotoxic activity of the anticancer agents. The patient was counseled to emphasize blueberries, blackberries, strawberries, raisins, raspberries, oranges, plums, red grapes, kale, beets, red bell peppers, brussels sprouts, onions, broccoli, eggplant, cabbage, bok choy, and collards in his diet. Each of these foods is particularly high in phytonutrients. Many of these compounds have been demonstrated to exert anticancer ability or to retain a high antioxidant capacity. The compounds found in many of these foods have also been demonstrated to inhibit cellular functions that are crucial to the longevity of a cancer cell. During periods when this child was unable to eat a variety of foods by mouth, the fruits and vegetables were made into a whey-based protein shake and administered orally or through the PEG. Whey was chosen as the base for the protein shake to provide additional support to his immune system.
Management of Side Effects of Conventional Therapies
This patient's chemotherapy and radiation therapy regimen is associated with severe weight loss, nausea and vomiting, mucositis, taste alterations, thrombocytopenia, immunosuppression, and neuropathy. Essential fatty acids were administered to aid in the management of cachexia. Supplementation with essential fatty acids was required to meet the recommended doses. These were complemented with the use of digestive bitters. Bitters were recommended at least 20 minutes prior to a meal. These preparations exert their effects through the stimulation of the salivary glands; however, due to the strong bitter taste, honey or agave nectar was added to enhance the flavor. The use of teas such as ginger, peppermint, or cinnamon was also recommended during periods of severe nausea or vomiting. Ginger and cinnamon were added to his food or ingested as a tea. Glutamine was recommended as a preventative agent for neuropathy. Glutamine was the foremost recommendation due to its broad spectrum of clinical application, including use for peripheral neuropathy. Glutamine has also demonstrated effectiveness in the prevention and treatment of mucositis and immunosuppression. This patient was also counseled on foods to support platelet regeneration. This patient was advised to eat at least a half cup to 1 cup of fresh beets during periods when he was at risk for thrombocytopenia. During periods when the patient was unable to ingest fresh beets, a beet extract was administered to the child. 
Elena Ladas, MS, RD
